Universe Pharmaceuticals INC (NASDAQ:UPC), a pharmaceutical company trading at $0.19 per share, announced today a change in its proposed share consolidation ratio. The company's stock has experienced ...

LONDON—Marlio Charles Mosseri, a significant shareholder in Nuvectis Pharma , Inc. (NASDAQ:NVCT), has made a notable purchase of company stock. According to a recent filing, Mosseri acquired 240,000 ...

Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.

CEO Jim Rechtin says investing in primary-care expansion remains a priority, albeit one that’s playing second fiddle to ...

More trouble brewing for BeerBiceps as Standing Committee on Information Technology is likely to issue a notice. Stay tuned with Mint to know what happens next ...